That is one but one of the issues with the Indian pharma space has been the regulatory issues and somehow these may start getting cleared. In some of the companies, prices have been moving in anticipation of that but the more endurable bet would be companies which are doing hard to manufacture ...
Read more: Budget push may see infra leading capex growth in pvt sector: Chetan Parikh